effect of 2% citric acid on control of spontaneous epistaxis i

Not Applicable

• Conditions: Epistaxis.; Epistaxis

• Registration Number: IRCT2012091510843N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

(to have spontaneous epistaxis)
Exclusion criteria: (to have a prior history of coagulopathy; trauma; vascular abnormalities)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
asal bleeding. Timepoint: 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: Physical examination by the physician.;Blood pressure. Timepoint: 2 minutes before and 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: By the physician using a Mercury sphygmomanometer.;Pulse rate per minute. Timepoint: 2 minutes before and 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: By the physician.